Retinal vascular complications associated with interferon‐ribavirin therapy for chronic hepatitis C: A population‐based study

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|27|2|191-198

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.27, Iss.2, 2018-02, pp. : 191-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 9, 2015-09 ,pp. : 1384-1390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Interferon and Ribavirin Therapy for Chronic Hepatitis C in Taiwan

By  

Intervirology, Vol. 49, Iss. 1-2, 2005-09 ,pp. : 91-95

Karger

Access to resources Recommend Favorite

Monitoring Virological Responses to Interferon-Ribavirin and Interferon Monotherapy of Chronic Hepatitis C Re-treated due to Relapse or Non-response

By Westin Johan   Lindh Magnus   Nenonen Nancy   Lagging L. Martin   Norkrans Gunnar   Wejstal Rune  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 2, 2001-01 ,pp. : 110-115

Informa Healthcare

Access to resources Recommend Favorite

Long-term Re-treatment with Interferon and Ribavirin Combination Therapy in Patients with Chronic Hepatitis C who are Non-responders to Interferon Alone: a Preliminary Study

By Vega P.   Castro A.   Hermida M.   López Calvo S.   Pedreira J.  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 4, 1999-09 ,pp. : 359-361

Informa Healthcare

Access to resources Recommend Favorite

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 46, Iss. 11, 2016-10 ,pp. : 1118-1128

John Wiley & Sons Inc

Access to resources Recommend Favorite